Clinical trials
Growth clinical trials
Below are recruiting growth clinical trials, each written for real people, not researchers. We’re tracking 297 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06516939Recruiting
Bovine growth factor gel for sensitive skin
This trial tests whether a gel containing a growth factor can help calm sensitive skin with redness. If you have persistent facial redness and stinging, this treatment might reduce irritation and improve skin comfort.
ShanghaiAges 18–60 - NCT06536582Recruiting
Nutrition’s role in PRGF treatment for shoulder tendon pain
This trial studies how diet affects the success of a special blood-based treatment (PRGF) for shoulder tendon pain. It may help you heal better from tendinopathy.
MilanAges 18–70 - NCT07231705Recruiting
Plant-based formula for growth and tolerance in toddlers
This study tests how well toddlers (12-17 months old) tolerate and grow on a plant-based formula. It compares this new formula to standard ones for children who get most of their calories from formula.
Columbus, OhioAges 1 year–1.4 years - NCT07024407RecruitingPhase 1/Phase 2
Study of andecaliximab for preventing bone growth after spinal cord injury
This trial tests a drug called andecaliximab to see if it can stop abnormal bone growth (heterotopic ossification) that sometimes happens after a spinal cord injury. It is for people who are at high risk for this bone growth and aims to prevent it from forming.
Denver, ColoradoAges 18–89 - NCT06985706RecruitingPhase 3
Comparing two treatments for diabetic eye swelling after initial injections
This trial tests whether switching from anti-VEGF injections to a special laser is better than continuing injections alone for people with diabetic macular edema whose central retinal thickness has dropped below 400 microns after the first year of treatment.
BelfastAges 18 years+ - NCT06970639RecruitingPhase 3
Study comparing new targeted drug plus chemo vs osimertinib for lung cancer with brain tumors
This trial tests a new targeted therapy called furmonertinib combined with chemotherapy against the current standard osimertinib for people with a specific type of non-small cell lung cancer (NSCLC) that has spread to the brain. It aims to find a better treatment option for patients whose cancer cells have a common EGFR mutation.
Guangdong, GuangzhouAges 18 years+ - NCT06011980Recruiting
Study for treating esophageal variceal bleeding in cirrhosis
This trial tests a treatment for patients with liver cirrhosis who have bleeding from their esophagus or stomach but are currently stable. It aims to help manage bleeding and improve outcomes.
Hanzhou, ZhejiangAges 18–70 - NCT07413939RecruitingPhase 2/Phase 3
Study of RO7771950 vs tucatinib for HER2-positive breast cancer
This trial tests a new drug, RO7771950, against another drug called tucatinib. Both are given with standard chemotherapy to see which works better for advanced breast cancer that is HER2-positive. People with brain metastases may join.
Germantown, TennesseeAges 18 years+ - NCT06625593RecruitingPhase 1
Study of BG-C137 for advanced solid tumors
This trial tests a new drug called BG-C137 for people with advanced solid tumors that have stopped responding to other treatments. The drug targets a protein called FGFR2b found on some cancer cells, aiming to deliver a therapy directly to the tumor.
Los Angeles, CaliforniaAges 18 years+ - NCT07309562RecruitingPhase 3
Growth hormone trial for short children born small
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
BeijingAges 2–11 - NCT07020546Recruiting
Ovarian PRP Injections for Better Embryo Quality
This trial tests whether injecting platelet-rich plasma (PRP) into your ovaries can improve the quality of your embryos. You will go through two IVF cycles, and the treatment aims to help women with low embryo quality get better results.
New York, New YorkAges 18–47 - NCT07323329RecruitingPhase 2/Phase 3
Growth Hormone and DHEA for IVF in Women with Low Ovarian Reserve
This trial tests whether adding growth hormone and DHEA to your IVF medications can help women with low ovarian reserve get more eggs and improve pregnancy chances. It may be an option if you are over 40, have had few eggs before, or have low egg count markers.
Banī Suwayf, Beni Suweif GovernorateAges 18–35 - NCT07272122RecruitingPhase 3
Reducing flies to lower illness in camps
This trial tests a method to reduce fly populations in camp settings to see if it can lower the spread of germs that cause diarrhea. The goal is to find a low-tech way to keep families healthier.
Bunj, Maban CountyAges 1 year+ - NCT06102928Recruiting
Anlotinib plus Aumolertinib for first-line treatment of advanced EGFR-mutant lung cancer
This trial tests a combination of two targeted drugs (anlotinib and aumolertinib) as the first treatment for advanced lung cancer with a specific EGFR mutation (L858R). The goal is to see if the combination works better than standard care.
Kunming, YunnanAges 18 years+ - NCT06667076RecruitingPhase 2
Amivantamab combinations for advanced EGFR-mutant lung cancer
This trial tests two treatment combinations for people with a specific type of advanced lung cancer that has an EGFR mutation. One group gets amivantamab plus lazertinib, and the other gets amivantamab plus chemotherapy. The goal is to see which combo works better.
Daphne, AlabamaAges 18 years+ - NCT05705531Recruiting
Cardiac MRI study of heart health after Hodgkin lymphoma treatment
This study looks at how certain blood-related “growth patterns” connect to long-term heart health after treatment for classical Hodgkin lymphoma. It may help doctors better predict who could develop heart problems and how to monitor them over time.
Mobile, AlabamaAges 7 years+ - NCT07524907Recruiting
Nutrition supplement study for children with slow growth
This study tests whether a special nutrition supplement can help young children (ages 1–5) who are not growing as expected. Researchers will work with Children International centers in the study area to see if the supplement helps children grow taller and healthier.
Kansas City, MissouriAges 1–5 - NCT04798690Recruiting
Long-term growth injections for short children
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
Seoul, Seodaemun-guAges 2 years+ - NCT03388606Recruiting
Studying adolescent depression and how to treat it
This study looks closely at how depression shows up in teens and tests approaches to treatment. It may help teens and families better understand depression and get access to structured care as part of research.
Los Angeles, CaliforniaAges 11–25 - NCT03283852Recruiting
Genetic study for certain childhood hormone and development disorders
This study looks for new genetic causes of certain “development disorders” that involve hormone problems and how the body develops at puberty. It may help families understand the root cause, which can guide future care and testing.
ParisAges Any age - NCT03396562Recruiting
Study of early development in babies with extra sex chromosomes
This study follows infants and young children with conditions caused by having an extra sex chromosome (like XXY, XYY, or XXX) to learn how health and development unfold over time. It may help families and doctors understand what to expect and what support could be helpful.
Aurora, ColoradoAges 1 month–1.1 years - NCT03402139Recruiting
Study early-life obesity risk after growth restriction
This study looks at how obesity risk may be influenced in children whose growth was lower than expected before birth. It enrolls mothers and babies together to learn whether early childhood obesity programming can help families.
The Bronx, New YorkAges 1 hour–2 years - NCT03648814Recruiting
Bevacizumab eye injections for neovascular glaucoma
This study compares two ways of giving the medicine bevacizumab in the eye: into the front part (intracameral) versus deeper inside (intravitreal). It aims to see which approach better controls neovascular glaucoma and helps vision, especially when surgery (trabeculectomy) is needed.
Hat Yai, Changwat SongkhlaAges 18 years+ - NCT03812913Recruiting
Brain and learning testing in girls with Turner syndrome
This study uses age-appropriate neuropsychological (thinking and learning) tests in girls to understand how brain functioning differs in Turner syndrome compared with isolated growth hormone deficiency. It may help doctors better assess learning and support needs.
Rennes, Ile Et VilaineAges 7–16
Hear when a new Growth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth?
- Yes. Clin2 currently lists 297 recruiting growth studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.